Exclusive

Publication

Byline

Nifty above 23,800 level; media shares in demand

Mumbai, May 15 -- The key equity benchmarks traded with modest gains in morning trade, buoyed by a record-breaking Wall Street session and constructive signals from the Trump-Xi summit in Beijing. How... Read More


Karnataka launches first-of-its-kind wild gaur relocation drive in Malnad region

Chikkamagaluru, May 15 -- With incidents of human-wildlife conflict increasing steadily across Karnataka's Malnad region, the state government and Forest Department have now initiated a first-of-its-k... Read More


छह साल में सबसे निचले स्तर पर पहुंची प्रयागराज एयरपोर्ट की उड़ानें

प्रयागराज, मई 15 -- प्रयागराज, वरिष्ठ संवाददाता। प्रयागराज एयरपोर्ट पर विमानों की आवाजाही लगातार घटती जा रही है। अप्रैल 2026 में यहां केवल 262 उड़ानों का संचालन हुआ, जो पिछले छह वर्षों में सबसे कम है।... Read More


Why JLR remains elephant in the room for Tata Motors despite domestic momentum

New Delhi, May 15 -- Tata Motors Passenger Vehicles Ltd's FY26 earnings showed that the domestic business is firing on all cylinders, but Jaguar Land Rover's troubles continue to overshadow the gains.... Read More


Singapore Clinical Trial: A Phase 1, Open-Label, Single Dose Study to Investigate the Relative Bioavailability, Safety, and Tolerability of Two Formulations of Eltrekibart in Healthy Participants

Singapore, May 15 -- The Health Sciences Authority received information related to the study titled 'A Phase 1, Open-Label, Single Dose Study to Investigate the Relative Bioavailability, Safety, and T... Read More


Singapore Clinical Trial: ROSETTA HCC-206: An Open-Label, Multi-Center, Randomized Phase 1/2 Study of Pumitamig Alone or In Combination with Ipilimumab in Participants with First-Line Advanced or Unresectable Hepatocellular Carcinoma (HCC)

Singapore, May 15 -- The Health Sciences Authority received information related to the study titled 'ROSETTA HCC-206: An Open-Label, Multi-Center, Randomized Phase 1/2 Study of Pumitamig Alone or In C... Read More


Clinical Trial: STRATegy SUccesS in High-Risk PCI With Impella CP: Evaluation of Hemodynamic Protection in Complex PCI

U.S., May 15 -- ClinicalTrials.gov registry received information related to the study (NCT07588399) titled 'STRATegy SUccesS in High-Risk PCI With Impella CP: Evaluation of Hemodynamic Protection in C... Read More


Singapore Clinical Trial: Phase II Open-label Study Evaluating Ivonescimab in PD-1 Resistant Recurrent or Metastatic Nasopharyngeal Carcinoma

Singapore, May 15 -- The Health Sciences Authority received information related to the study titled 'Phase II Open-label Study Evaluating Ivonescimab in PD-1 Resistant Recurrent or Metastatic Nasophar... Read More


Clinical Trial: Artificial Intelligence (AI)-Assisted Sleep Intervention for Insomnia in Older Adults With Subjective Cognitive Decline

U.S., May 15 -- ClinicalTrials.gov registry received information related to the study (NCT07588035) titled 'Artificial Intelligence (AI)-Assisted Sleep Intervention for Insomnia in Older Adults With S... Read More


Singapore Clinical Trial: A Phase 2 Multi-center, Randomized, Open-label Study to Assess the Efficacy and Safety of AHB-137 in Nucleos(t)ide Analogue-treated Participants with HBeAg Negative Chronic Hepatitis B in the Asia Pacific Region

Singapore, May 15 -- The Health Sciences Authority received information related to the study titled 'A Phase 2 Multi-center, Randomized, Open-label Study to Assess the Efficacy and Safety of AHB-137 i... Read More